{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:14:47Z","timestamp":1788941687166,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"he Open Project of Luzhou Key Laboratory of Basic and Clinical Application Research on Wound Repair, School of Nursing, Southwest Medical University","award":["No. 2025KFKTZD30"],"award-info":[{"award-number":["No. 2025KFKTZD30"]}]},{"name":"Sichuan Medical Association Scientific Research Projec","award":["No. 2021TG01"],"award-info":[{"award-number":["No. 2021TG01"]}]},{"name":"Luzhou Science and Technology Bureau Scientific Research Project","award":["No. 2022-SYF-89"],"award-info":[{"award-number":["No. 2022-SYF-89"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00210-026-05167-2","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T03:16:24Z","timestamp":1773026184000},"page":"12289-12303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of the species distribution and drug resistance of pathogenic microorganisms causing diabetic foot infections in Southwest China from 2020 to 2024: a retrospective cross-sectional analysis"],"prefix":"10.1007","volume":"399","author":[{"given":"Shangyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusen","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"7","key":"5167_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(sici)1096-9136(199807)15:7<539::Aid-dia668>3.0.Co;2-s","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15(7):539\u2013553. https:\/\/doi.org\/10.1002\/(sici)1096-9136(199807)15:7%3c539::Aid-dia668%3e3.0.Co;2-s","journal-title":"Diabet Med"},{"issue":"1","key":"5167_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5144\/0256-4947.2007.25","volume":"27","author":"F Al-Mahroos","year":"2007","unstructured":"Al-Mahroos F, Al-Roomi K (2007) Diabetic neuropathy, foot ulceration, peripheral vascular disease and potential risk factors among patients with diabetes in Bahrain: a nationwide primary care diabetes clinic-based study. Ann Saudi Med 27(1):25\u201331. https:\/\/doi.org\/10.5144\/0256-4947.2007.25","journal-title":"Ann Saudi Med"},{"issue":"3","key":"5167_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/wound.2021.0072","volume":"12","author":"J Arag\u00f3n-S\u00e1nchez","year":"2023","unstructured":"Arag\u00f3n-S\u00e1nchez J et al (2023) Does metabolic control have any influence on the clinical presentation and short-term outcomes of diabetic foot infections? Adv Wound Care 12(3):135\u2013144. https:\/\/doi.org\/10.1089\/wound.2021.0072","journal-title":"Adv Wound Care"},{"key":"5167_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13142366","author":"A Ardelean","year":"2023","unstructured":"Ardelean A et al (2023) Pentraxin-3 and other inflammatory markers for an infected diabetic foot ulcer diagnosis: a prospective study. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics13142366","journal-title":"Diagnostics"},{"issue":"2-4","key":"5167_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1053\/j.semvascsurg.2019.02.001","volume":"31","author":"DF Bandyk","year":"2018","unstructured":"Bandyk DF (2018) The diabetic foot: pathophysiology, evaluation, and treatment. Semin Vasc Surg 31(2\u20134):43\u201348. https:\/\/doi.org\/10.1053\/j.semvascsurg.2019.02.001","journal-title":"Semin Vasc Surg"},{"issue":"12","key":"5167_CR6","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1055\/a-1149-8989","volume":"129","author":"S D\u00f6rr","year":"2021","unstructured":"D\u00f6rr S et al (2021) Predictive effect of inflammatory response and foot ulcer localization on outcome in younger and older individuals with infected diabetic foot syndrome. Exp Clin Endocrinol Diabetes 129(12):878\u2013886. https:\/\/doi.org\/10.1055\/a-1149-8989","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"5167_CR7","doi-asserted-by":"publisher","first-page":"881659","DOI":"10.3389\/fendo.2022.881659","volume":"13","author":"F Du","year":"2022","unstructured":"Du F et al (2022) Microbial infection and antibiotic susceptibility of diabetic foot ulcer in China: literature review. Front Endocrinol (Lausanne) 13:881659. https:\/\/doi.org\/10.3389\/fendo.2022.881659","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5167_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12122775","author":"F Farine","year":"2024","unstructured":"Farine F et al (2024) Predictive factors of amputation in diabetic foot. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12122775","journal-title":"Biomedicines"},{"key":"5167_CR9","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16162","volume":"11","author":"H Guo","year":"2023","unstructured":"Guo H et al (2023) Distribution of multidrug-resistant bacterial infections in diabetic foot ulcers and risk factors for drug resistance: a retrospective analysis. PeerJ 11:e16162. https:\/\/doi.org\/10.7717\/peerj.16162","journal-title":"PeerJ"},{"key":"5167_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106363","volume":"184","author":"MS Khan","year":"2023","unstructured":"Khan MS et al (2023) Identification of contributing factors, microorganisms and antimicrobial resistance involved in the complication of diabetic foot ulcer treatment. Microb Pathog 184:106363. https:\/\/doi.org\/10.1016\/j.micpath.2023.106363","journal-title":"Microb Pathog"},{"key":"5167_CR11","doi-asserted-by":"publisher","unstructured":"Li X et al (2021) Research on the current situation and influencing factors of foot risk screening in diabetic patients. J Nurs 36(09):33\u201336. https:\/\/doi.org\/10.3870\/j.issn.1001-4152.2021.09.033. (Chinese)","DOI":"10.3870\/j.issn.1001-4152.2021.09.033"},{"issue":"1","key":"5167_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07382-7","volume":"22","author":"X Li","year":"2022","unstructured":"Li X et al (2022) Distribution and drug sensitivity of pathogenic bacteria in diabetic foot ulcer patients with necrotizing fasciitis at a diabetic foot center in China. BMC Infect Dis 22(1):396. https:\/\/doi.org\/10.1186\/s12879-022-07382-7","journal-title":"BMC Infect Dis"},{"key":"5167_CR13","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.2147\/idr.S359157","volume":"15","author":"X Liu","year":"2022","unstructured":"Liu X et al (2022) Risk factors for multidrug-resistant organisms infection in diabetic foot ulcer. Infect Drug Resist 15:1627\u20131635. https:\/\/doi.org\/10.2147\/idr.S359157","journal-title":"Infect Drug Resist"},{"key":"5167_CR14","doi-asserted-by":"publisher","first-page":"1113622","DOI":"10.3389\/fendo.2023.1113622","volume":"14","author":"W Liu","year":"2023","unstructured":"Liu W et al (2023) Distribution of microbes and antimicrobial susceptibility in patients with diabetic foot infections in South China. Front Endocrinol (Lausanne) 14:1113622. https:\/\/doi.org\/10.3389\/fendo.2023.1113622","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5167_CR15","doi-asserted-by":"publisher","unstructured":"Liu Jiawei et al (2024) Distribution and drug resistance analysis of pathogenic microorganisms in 277 cases of diabetic foot infections. J Army Med Univ 46(23):2655\u20132660 (Chinese). https:\/\/doi.org\/10.16016\/j.2097-0927.202405104","DOI":"10.16016\/j.2097-0927.202405104"},{"issue":"3","key":"5167_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268\u2013281. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"5167_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.12968\/jowc.2019.28.5.261","volume":"28","author":"M Mairghani","year":"2019","unstructured":"Mairghani M et al (2019) Methodological approaches for assessing the cost of diabetic foot ulcers: a systematic literature review. J Wound Care 28(5):261\u2013266. https:\/\/doi.org\/10.12968\/jowc.2019.28.5.261","journal-title":"J Wound Care"},{"key":"5167_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcdhc.2024.1393309","volume":"5","author":"S Maity","year":"2024","unstructured":"Maity S et al (2024) A systematic review of diabetic foot infections: pathogenesis, diagnosis, and management strategies. Front Clin Diab Healthcare 5:1393309. https:\/\/doi.org\/10.3389\/fcdhc.2024.1393309","journal-title":"Front Clin Diab Healthcare"},{"issue":"Suppl 2","key":"5167_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12262-012-0791-2","volume":"77","author":"IC Muduli","year":"2015","unstructured":"Muduli IC et al (2015) Diabetic foot ulcer complications and its management-a medical college-based descriptive study in Odisha, an Eastern State of India. Indian J Surg 77(Suppl 2):270\u2013274. https:\/\/doi.org\/10.1007\/s12262-012-0791-2","journal-title":"Indian J Surg"},{"issue":"Suppl 7","key":"5167_CR20","doi-asserted-by":"publisher","first-page":"S521","DOI":"10.1093\/cid\/ciz824","volume":"69","author":"P Nordmann","year":"2019","unstructured":"Nordmann P, Poirel L (2019) Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria. Clin Infect Dis 69(Suppl 7):S521-s528. https:\/\/doi.org\/10.1093\/cid\/ciz824","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5167_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2337\/dci23-0085","volume":"47","author":"ED Parker","year":"2024","unstructured":"Parker ED et al (2024) Economic costs of diabetes in the U.S. in 2022. Diabetes Care 47(1):26\u201343. https:\/\/doi.org\/10.2337\/dci23-0085","journal-title":"Diabetes Care"},{"issue":"2 Suppl","key":"5167_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.26355\/eurrev_201904_17471","volume":"23","author":"D Pitocco","year":"2019","unstructured":"Pitocco D et al (2019) Diabetic foot infections: a comprehensive overview. Eur Rev Med Pharmacol Sci 23(2 Suppl):26\u201337. https:\/\/doi.org\/10.26355\/eurrev_201904_17471","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"5167_CR23","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P et al (2019) Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 157:107843. https:\/\/doi.org\/10.1016\/j.diabres.2019.107843","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"5167_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3687","volume":"40","author":"\u00c9 Senneville","year":"2024","unstructured":"Senneville \u00c9 et al (2024) IWGDF\/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF\/IDSA 2023). Diabetes Metab Res Rev 40(3):e3687. https:\/\/doi.org\/10.1002\/dmrr.3687","journal-title":"Diabetes Metab Res Rev"},{"key":"5167_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18041891","author":"CH Tai","year":"2021","unstructured":"Tai CH et al (2021) Prevalence and medical resource of patients with diabetic foot ulcer: a nationwide population-based retrospective cohort study for 2001-2015 in Taiwan. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph18041891","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"5167_CR26","doi-asserted-by":"publisher","first-page":"e23900","DOI":"10.1016\/j.heliyon.2023.e23900","volume":"10","author":"XF Tang","year":"2024","unstructured":"Tang XF et al (2024) Baseline high-sensitivity C-reactive protein and glycosylated hemoglobinA1c predict adverse outcomes in patients with chronic coronary syndromes undergoing percutaneous coronary intervention. Heliyon 10(1):e23900. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23900","journal-title":"Heliyon"},{"key":"5167_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkaa017","volume":"8","author":"A Wang","year":"2020","unstructured":"Wang A et al (2020) Guidelines on multidisciplinary approaches for the prevention and management of diabetic foot disease (2020 edition). Burns & Trauma 8:tkaa017. https:\/\/doi.org\/10.1093\/burnst\/tkaa017","journal-title":"Burns & Trauma"},{"issue":"12","key":"5167_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.25270\/wnds\/082421.03","volume":"35","author":"YT Wang","year":"2023","unstructured":"Wang YT et al (2023) Inflammatory markers in diabetic foot infection: a meta-analysis. Wounds 35(12):425\u2013432. https:\/\/doi.org\/10.25270\/wnds\/082421.03","journal-title":"Wounds"},{"key":"5167_CR29","doi-asserted-by":"publisher","unstructured":"Wu J et al (2023) Characteristics of inflammatory markers in diabetic foot patients and their relationship with prognosis of diabetic foot ulcers. Sichuan Da Xue Xue Bao Yi Xue Ban 54(6):1233\u20131238.\u00a0https:\/\/doi.org\/10.12182\/20230960506","DOI":"10.12182\/20230960506"},{"issue":"7","key":"5167_CR30","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s13300-024-01601-x","volume":"15","author":"M Wu","year":"2024","unstructured":"Wu M et al (2024) Analysis of distribution and drug susceptibility test results of pathogenic bacteria in diabetic foot ulcers. Diabetes Ther 15(7):1627\u20131637. https:\/\/doi.org\/10.1007\/s13300-024-01601-x","journal-title":"Diabetes Ther"},{"issue":"12","key":"5167_CR31","doi-asserted-by":"publisher","first-page":"12618","DOI":"10.21037\/apm-21-3406","volume":"10","author":"W Xia","year":"2021","unstructured":"Xia W et al (2021) Risk factors for multidrug-resistant bacterial infections in patients with diabetic foot ulcers: a systematic review and meta-analysis. Ann Palliat Med 10(12):12618\u201312630. https:\/\/doi.org\/10.21037\/apm-21-3406","journal-title":"Ann Palliat Med"},{"key":"5167_CR32","doi-asserted-by":"publisher","unstructured":"Yang G et al (2022) Analysis of the distribution and drug resistance patterns of pathogenic microorganisms in diabetic foot infections. Chin J Integr Tradit West Surg 28(06):775\u2013779. https:\/\/doi.org\/10.3969\/j.issn.1007-6948.2022.06.004. (Chinese)","DOI":"10.3969\/j.issn.1007-6948.2022.06.004"},{"key":"5167_CR33","doi-asserted-by":"publisher","unstructured":"Zhang Y et al (2021) Risk factors affecting diabetic foot and the impact of ulcer severity on prognosis. Chin J Gerontol 41(22):4911\u20134914. https:\/\/doi.org\/10.3969\/j.issn.1005-9202.2021.22.012. (Chinese)","DOI":"10.3969\/j.issn.1005-9202.2021.22.012"},{"issue":"10","key":"5167_CR34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3969\/j.issn.1005-8982.2023.10.017","volume":"33","author":"S Zhan","year":"2023","unstructured":"Zhan S et al (2023) Establishment of a risk prediction model for pathogenic microorganisms in diabetic foot infections. Chinese Journal of Modern Medicine 33(10):95\u2013100. https:\/\/doi.org\/10.3969\/j.issn.1005-8982.2023.10.017. (Chinese)","journal-title":"Chinese Journal of Modern Medicine"},{"issue":"5","key":"5167_CR35","doi-asserted-by":"publisher","first-page":"964","DOI":"10.2337\/dc19-1614","volume":"43","author":"Y Zhang","year":"2020","unstructured":"Zhang Y et al (2020) Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016. Diabetes Care 43(5):964\u2013974. https:\/\/doi.org\/10.2337\/dc19-1614","journal-title":"Diabetes Care"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05167-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05167-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05167-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:20:19Z","timestamp":1781511619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05167-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5167"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05167-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This cross-sectional survey was conducted in accordance with the Declaration of Helsinki. The Clinical Trial Ethics Committee of the Affiliated Hospital of Southwest Medical University has approved this study, with approval number KY2025259. As this study is a retrospective one, mainly utilizing existing medical record data, and the data were anonymized during the analysis process to protect patients\u2019 privacy and avoid imposing additional risks or burdens on them, the ethics committee exempted the need for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not Applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}